Neurochemical Pathogenesis of Fibromyalgia Syndrome

REFERENCES

• Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum, 33: 160–172, 1990
   PubMed Web of Science ®Google Scholar
• Malmberg A B, Yaksh T L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257: 1276–1279
   PubMed Web of Science ®Google Scholar
• Russell I J. Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoske Pain 1996; 1(1/2)61–92
   Google Scholar
• Murphy R M, Zemlan F P. Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes. Psychopharmacology (Berlin) 1987; 93: 118–121
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Warsh J J. Plasma tryptophan and musculoskeletal pain in nonarticular rheumatism (“fibrositis syndrome”). Pain 1978; 5: 65–71
   PubMed Web of Science ®Google Scholar
• Russell I J, Michalek J E, Vipraio G A, Fletcher E M, Javors M A, Bowden C A. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992; 19: 104–109
   PubMed Web of Science ®Google Scholar
• Hrycaj P, Stratz T, Muller W. Platelet 3H-imipramine uptake receptor density and serum serotonin in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1993; 20: 1986–1987
   PubMed Web of Science ®Google Scholar
• Russell I J, Vipraio G A. Serotonin (5HT) in serum and platelets (PLT) from fibromyalgia patients (FS) and normal controls (NC). Arthritis Rheum 1994; 37(Suppl)S214
   Google Scholar
• Russell I J, Vipraio G A, Acworth I. Abnormalities in the central nervous system [CNS] metabolism of tryptophan [TRY] to 3-hydroxy kynurenine [OHKY] in fibromyalgia syndrome [FS]. Arthritis Rheum 1993; 36(9)S222, (Abstract)
   PubMed Web of Science ®Google Scholar
• Russell I J, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35: 550–556
   PubMed Web of Science ®Google Scholar
• Kang Y-K, Russell I J, Vipraio G A, Acworth I N. Low urinary 5-hydroxyindole acetic acid in fibromyalgia syndrome: Evidence in support of a serotonin-deficiency pathogenesis. Myalgia 1998; 1: 14–21
   Google Scholar
• Hoheisel U, Mense S, Ratkai M. Effects of spinal cord superfusion with substance P on the excitability of rat dorsal horn neurons processing input from deep tissues. J Musculoske Pain 1995; 3(3)23–43
   Google Scholar
• Schwarz M J, Spath M, Muller-Bardow H, Pongratz D E, Akenheil M. Substance P, 5-HIAA and tryptophan in serum of fibromyalgia patients. Abstract presented at MYOPAIN '98, Chieti, Italy, August. 1998
   Google Scholar
• Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 1988; 32: 21–26
   PubMed Web of Science ®Google Scholar
• Russell I J, Orr M D, Littman B, Vipraio G A, Alboukrek D, Michalek J E, Lopez Y, MacKillip F. Elevated cerebrospinal levels of substance P patients fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593–1601
   PubMed Web of Science ®Google Scholar
• Welin M, Bragee B, Nyberg F, Kristiansson M. Elevated substance P levels are contrasted by a decrease in met-enkephalin-ar-gphe levels in csf from fibromyalgia patients. J Musculoske Pain 1995; 3(Suppl 1), 4, (Abstract)
   Google Scholar
• Bradley L A, Alberts K R, Alarcon G S, Alexander M T, Mountz J M, Weigent D A, Liu H G, Blalock J E, Aaron L A, Alexander R W, San Pedro E C, Martin M Y, Morell A C. Abnormal brain regional cerebral blood flow (rCBF) and cerebrospinal fluid (CSF) levels of substance P (SP) in patients and non-patients with fibromyalgia (FM). Arthritis Rheum 1996; 39(Supplement)S212, (Abstract)
   Google Scholar
• Russell I J, Fletcher E M, Vipraio G A, Lopez Y, Orr M A. Cerebrospinal fluid [CSF] substance P [SP] in fibromyalgia: Changes in CSF SP over time parallel changes in clinical activity. J Musculoske Pain 1998; 6(Suppl 2)77
   Google Scholar
• Sjostrom S, Tamsen A, Hartvig P, Folkesson R, Terenius L. Cerebrospinal fluid concentrations of substance P and (met) enkephalin-Arg6-Phe7 during surgery and patient-controlled analgesia. Anesth Analg 1988; 67: 976–981
   PubMed Web of Science ®Google Scholar
• Nyberg F, Liu Z, Lind C, Thornwall M, Ordeberg G. Enhanced CSF levels of substance P in patients with painful arthrosis but not in patients with pain from herniated lumbar discs. J Musculoske Pain 1995; 3(Suppl 1), 2, (Abstract)
   Google Scholar
• Nyberg F, LeGreves P, Sundqvist C, Terenius L. Characterization of substance P (1–7) and (1–8) generating enzyme in human cerebrospinal fluid. Biochem Biophys Res Commun 1984; 125: 244–250
   PubMed Web of Science ®Google Scholar
• Skilling S R, Smullin D H, Larson A A. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception. Journal of Neuroscience 1990; 10: 1309–1318
   PubMed Web of Science ®Google Scholar
• Yukhananov RYu, Larson A A. An N-terminal fragment of substance P, substance P (1–7), down-regulates neurokinin-1 binding in the mouse spinal cord. Neurosci Lett 1994; 178: 163–166
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Nyberg F, Terenius L. No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7. Pain 1991; 46: 139–143
   PubMed Web of Science ®Google Scholar
• Russell I J. Possible role for central neurochemicals. Am J Med Sci 1998; 315: 377–384
   PubMed Web of Science ®Google Scholar
• Vanderah T W, Laughlin T, Lashbrook J M, Nichols M L, Wilcox G L, Ossipov M H, Malan T P, Jr., Porreca F, Ossipov M H, Malan T P, Jr. Single intrathecal injections of dynorphin A or des-tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 1996; 68: 275–281
   PubMed Web of Science ®Google Scholar
• Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F. Increased rates of fibromyalgia following cervical spine injury: A controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997; 40: 446–452
   PubMed Web of Science ®Google Scholar